IP Library Granted Patent US 9,447,445
Granted Patent B2
US 9,447,445 · App. 14/837,820 · Granted Sep 20, 2016

Synthon formation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,447,445
App. No.
14/837,820
Granted
Sep 20, 2016
Kind
B2
Abstract

This disclosure provides, among other things, a composition comprising: a 5′ exonuclease; a strand-displacing polymerase; and optionally a single strand DNA binding protein and/or a ligase. A method for polynucleotide assembly to form a synthon, as well as a kit for performing the same, are also described.

Claims (35)

1. A preparation, comprising:

a fusion protein comprising an amino acid sequence that has at least 90% sequence identity to SEQ ID NO:3, wherein the fusion protein comprises:

(i) an amino acid sequence that has at least 90% sequence identity to SEQ ID NO:1; and

(ii) an amino acid sequence that has at least 90% sequence identity to SEQ ID NO:2.

2. The preparation according to claim 1 , further comprising a 5′-3′ exonuclease.

3. The preparation according to claim 2 , wherein the 5′-3′ exonuclease is T5 exonuclease.

4. The preparation according to claim 1 , further comprising a single strand DNA binding protein.

5. The preparation according to claim 4 , wherein the single strand DNA binding protein is ET SSB (Extreme Thermostable Single-Stranded DNA Binding Protein), E. coli recA, T7 gene 2.5 product, phage lambda RedB or Rac prophage RecT.

6. The preparation according to claim 1 , further comprising a ligase.

7. The preparation of claim 1 , wherein the preparation does not comprise a crowding agent and/or a non strand-displacing polymerase.

8. The preparation of claim 1 , further comprising a potassium salt.

9. The preparation according to claim 1 , further comprising a plurality of polynucleotides in a set wherein at least a polynucleotide in the set has a sequence that overlaps with another polynucleotide in the set; and wherein the polynucleotides are selected from: (i) double stranded polynucleotides; (ii) single stranded oligonucleotides; (iii) at least one double strand polynucleotide and at least one single strand oligonucleotide; and (iv) a subpopulation of polynucleotides that are otherwise identical to one another except for a sequence that varies between the members of the sub-population.

10. The preparation according to claim 9 , wherein the set of polynucleotides has at least 3 members or at least 4 members or at least 5 members.

11. A method for producing a synthon, comprising:

incubating a preparation according to claim 2 further optionally comprising a ligase and a single strand DNA binding protein, with a plurality of polynucleotides that form a set, wherein members of the set have sequences that overlap under suitable reaction conditions; and

joining at least two the polynucleotides to produce a synthon.

12. The method according to claim 11 , wherein the set of polynucleotides contains at least 3 members or at least 4 members or at least 5 members.

13. The method according to claim 11 , wherein the preparation further comprises a ligase.

14. The method according to claim 11 , wherein the preparation further comprises a single strand DNA binding protein.

15. The method according to claim 11 , wherein the polynucleotides are double stranded and the double strand polynucleotides are overlapping PCR products, overlapping restriction fragments or assembled from single stranded oligonucleotides.

16. The method according to claim 11 , wherein the polynucleotides are single stranded oligonucleotides.

17. The method according to claim 11 , wherein the set of polynucleotides comprises at least one double strand polynucleotide and at least one single strand oligonucleotide.

18. A kit for polynucleotide assembly, comprising:

(a) a preparation according to claim 1 ; and

(b) a 5′-3′ exonuclease.

19. A kit according to claim 18 , further comprising a single strand binding protein.

20. The kit according to claim 18 , further comprising a ligase.

21. The kit according to claim 18 , further comprising a buffering agent.

22. The kit according to claim 18 , wherein the 5′-3′ exonuclease is T5 exonuclease.

23. The kit according to claim 18 , does not include a crowding agent.

24. The kit according to claim 18 , wherein (a)-(b) are in the same vessel.

25. The preparation according to claim 1 , wherein the fusion protein comprises an amino acid sequence that has at least 95% identity to SEQ ID NO:3, wherein the fusion protein comprises:

(i) an amino acid sequence that has at least 95% sequence identity to SEQ ID NO:1; and

(ii) an amino acid sequence that has at least 95% sequence identity to SEQ ID NO:2.

26. The preparation according to claim 1 , wherein the fusion protein comprising the amino acid sequence of SEQ ID NO:3.

Assignments (2)
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Sep 27, 2023
From: NEW ENGLAND BIOLABS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065044/0729 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 1, 2015
From: HSIEH, PEI-CHUNG; SUN, LUO; EVANS, THOMAS C., JR.; DAVIS, THEODORE B.; GARDNER, ANDREW
To: NEW ENGLAND BIOLABS, INC.
Reel/Frame 036464/0727 →